FI890419A - Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazin-, pyrimidin- och pyridazinderivat. - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazin-, pyrimidin- och pyridazinderivat. Download PDF

Info

Publication number
FI890419A
FI890419A FI890419A FI890419A FI890419A FI 890419 A FI890419 A FI 890419A FI 890419 A FI890419 A FI 890419A FI 890419 A FI890419 A FI 890419A FI 890419 A FI890419 A FI 890419A
Authority
FI
Finland
Prior art keywords
pyridazinderivat
pyrazin
pyrimidin
och
foerfarande foer
Prior art date
Application number
FI890419A
Other languages
English (en)
Other versions
FI890419A0 (fi
Inventor
Raymond Baker
John Saunders
Leslie J Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888802101A external-priority patent/GB8802101D0/en
Priority claimed from GB888815225A external-priority patent/GB8815225D0/en
Priority claimed from GB888817812A external-priority patent/GB8817812D0/en
Priority claimed from GB888821088A external-priority patent/GB8821088D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of FI890419A0 publication Critical patent/FI890419A0/fi
Publication of FI890419A publication Critical patent/FI890419A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI890419A 1988-01-30 1989-01-27 Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazin-, pyrimidin- och pyridazinderivat. FI890419A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888802101A GB8802101D0 (en) 1988-01-30 1988-01-30 Therapeutic agents
GB888815225A GB8815225D0 (en) 1988-06-27 1988-06-27 Therapeutic agents
GB888817812A GB8817812D0 (en) 1988-07-26 1988-07-26 Therapeutic agents
GB888821088A GB8821088D0 (en) 1988-09-08 1988-09-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
FI890419A0 FI890419A0 (fi) 1989-01-27
FI890419A true FI890419A (fi) 1989-07-31

Family

ID=27450036

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890419A FI890419A (fi) 1988-01-30 1989-01-27 Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazin-, pyrimidin- och pyridazinderivat.

Country Status (10)

Country Link
EP (1) EP0327155A3 (fi)
JP (1) JPH02111768A (fi)
KR (1) KR890011860A (fi)
AU (1) AU622141B2 (fi)
DK (1) DK35389A (fi)
FI (1) FI890419A (fi)
IL (1) IL89034A0 (fi)
NO (1) NO890364L (fi)
NZ (1) NZ227684A (fi)
PT (1) PT89523B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
US5177084A (en) * 1989-08-08 1993-01-05 Merck Sharp & Dohme Ltd. Therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes
GB8918060D0 (en) * 1989-08-08 1989-09-20 Merck Sharp & Dohme Therapeutic agents
EP0413545B1 (en) * 1989-08-16 1997-05-14 Beecham Group Plc Azabicyclic compounds
GB9005737D0 (en) * 1990-03-14 1990-05-09 Beecham Group Plc Novel compounds
DK72790D0 (da) * 1990-03-21 1990-03-21 Ferrosan As Heterocycliske forbindelser, deres fremstilling og anvendelse
GB9017353D0 (en) * 1990-08-08 1990-09-19 Merck Sharp & Dohme Chemical process
CA2050264A1 (en) * 1990-08-30 1992-03-01 Raymond Baker Substituted pyrazine and its salts, compositions containing them and their use in medicine
EP0492902A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP &amp; DOHME LTD. Substituted pyridine derivatives for use in the treatment of glaucoma
EP0492903A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP &amp; DOHME LTD. Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
GB9201749D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Plc Medicaments
AU672644B2 (en) * 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
CA2238555A1 (en) * 1995-11-29 1997-06-05 Charles Howard Mitch Heterocyclic compounds and their use
US5889019A (en) * 1995-11-29 1999-03-30 Eli Lilly And Company Heterocyclic compounds and their use
US5834458A (en) * 1996-10-09 1998-11-10 Eli Lilly And Company Heterocyclic compounds and their use
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
CA2287223A1 (en) * 1997-04-26 1998-11-05 Tomohiro Toyoda 2-azabicyclo compounds
EE200200453A (et) * 2000-02-16 2003-12-15 Neurogen Corporation Asendatud arüülpürasiinid
US20060025468A1 (en) * 2004-07-29 2006-02-02 Whitten Jeffrey P Chiral pyrrolidine derivatives, and methods for preparing compounds thereof
JP2007032031A (ja) * 2005-07-25 2007-02-08 Sanyo Industries Ltd 持出し手摺構造及びその取付け方法
BR122020005073A2 (pt) 2017-08-04 2020-10-13 Skyhawk Therapeutics, Inc. Composto, composição farmacêutica e uso do composto
JP2022519636A (ja) * 2019-02-04 2022-03-24 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
CN114007611A (zh) * 2019-02-04 2022-02-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
KR20210135241A (ko) 2019-02-05 2021-11-12 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
KR20210135507A (ko) 2019-02-06 2021-11-15 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911710B1 (fi) * 1970-12-30 1974-03-19
JPS4911710A (fi) * 1972-05-15 1974-02-01
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
ZA842595B (en) * 1983-04-14 1985-11-27 Hoffmann La Roche Pyrimidine derivatives
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
ATE133415T1 (de) * 1987-04-15 1996-02-15 Beecham Group Plc Am brückenkopf substituierte azabicyclenderivate
CA2000041A1 (en) * 1988-10-13 1990-04-13 Barry S. Orlek Compounds

Also Published As

Publication number Publication date
KR890011860A (ko) 1989-08-23
AU2883489A (en) 1989-08-03
JPH02111768A (ja) 1990-04-24
FI890419A0 (fi) 1989-01-27
DK35389A (da) 1989-07-31
NO890364L (no) 1989-07-31
IL89034A0 (en) 1989-08-15
NZ227684A (en) 1991-07-26
PT89523A (pt) 1989-10-04
EP0327155A2 (en) 1989-08-09
AU622141B2 (en) 1992-04-02
PT89523B (pt) 1994-02-28
NO890364D0 (no) 1989-01-27
DK35389D0 (da) 1989-01-27
EP0327155A3 (en) 1992-01-02

Similar Documents

Publication Publication Date Title
FI890419A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazin-, pyrimidin- och pyridazinderivat.
FI880420A (fi) Anordning foer bestrykning av materialbana.
FI880557A0 (fi) Foerfarande foer momentkontroll av en vaexelstroemsmaskin.
FI880233A (fi) Anordning foer skaerpning av knivar.
FI881437A0 (fi) Anordning foer manoevrering av tvao kopplingsanordningar.
FI881079A0 (fi) Anlaeggning foer boejning av glasskivor.
FI880667A0 (fi) Anordning foer haerdning av isoleringsroer.
FI880703A0 (fi) Foerfarande foer konversion av kolvaeten.
FI881012A0 (fi) Foerfarande foer framstaellning av en bergsko foer betongpaolar.
FI880141A0 (fi) Avsoekande elektronmikroskop foer visualisering av loesningsprov.
FI880191A0 (fi) Foerfarande foer oekning av friktion.
FI880211A0 (fi) Anordning foer medlaeggning av draeneringsroer.
FI880327A0 (fi) Sanitetsarmatur foer aostadkommande av dubbeldusch.
FI880378A0 (fi) Arbetsverktyg foer loesgoerande av ventilkilar.
FI880403A0 (fi) Foerfarande foer framstaellning av fuktvatten foer litografiskt tryck.
FI880447A (fi) Foerfarande foer byggande av underbyggnad foer konstis.
FI880448A (fi) Foerfarande foer laeggning av kylroer.
FI880092A0 (fi) Fogningskonstruktion av eldstadsdelar.
FI880490A0 (fi) Anordning foer montering av byggnadselement.
FI880773A0 (fi) Foerfarande foer framstaellning av gummistoevel.
FI880829A0 (fi) Lockmembrankonstruktion av en foerpackning.
FI880940A0 (fi) Foerfarande foer framstaellning av disackaridderivat.
FI880971A0 (fi) Foerfarande foer framstaellning av en valsbelaeggning.
FI880070A0 (fi) Skydd foer foerhindrande av igenfrysning av dagvatten- och avfallsvattenbrunnar.
FI881128A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbart nikotinsyra-litiumsaltsemihydrat.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MERCK SHARP & DOHME LIMITED